GE HEALTHCARE TECHNOLOGY (GEHC) Stock Fundamental Analysis

NASDAQ:GEHC • US36266G1076

84.23 USD
+1.22 (+1.47%)
At close: Feb 20, 2026
84.8155 USD
+0.59 (+0.7%)
After Hours: 2/20/2026, 6:37:49 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

GEHC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While GEHC has a great profitability rating, there are quite some concerns on its financial health. GEHC is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year GEHC was profitable.
  • GEHC had a positive operating cash flow in the past year.
  • GEHC had positive earnings in 4 of the past 5 years.
  • GEHC had a positive operating cash flow in 4 of the past 5 years.
GEHC Yearly Net Income VS EBIT VS OCF VS FCFGEHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

  • The Return On Assets of GEHC (6.14%) is better than 85.41% of its industry peers.
  • GEHC has a better Return On Equity (22.19%) than 95.68% of its industry peers.
  • GEHC has a better Return On Invested Capital (7.77%) than 83.78% of its industry peers.
  • GEHC had an Average Return On Invested Capital over the past 3 years of 8.36%. This is in line with the industry average of 8.75%.
Industry RankSector Rank
ROA 6.14%
ROE 22.19%
ROIC 7.77%
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
GEHC Yearly ROA, ROE, ROICGEHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

  • GEHC has a better Profit Margin (10.95%) than 85.41% of its industry peers.
  • In the last couple of years the Profit Margin of GEHC has grown nicely.
  • Looking at the Operating Margin, with a value of 13.52%, GEHC belongs to the top of the industry, outperforming 81.62% of the companies in the same industry.
  • GEHC's Operating Margin has been stable in the last couple of years.
  • The Gross Margin of GEHC (40.80%) is worse than 66.49% of its industry peers.
  • In the last couple of years the Gross Margin of GEHC has remained more or less at the same level.
Industry RankSector Rank
OM 13.52%
PM (TTM) 10.95%
GM 40.8%
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
GEHC Yearly Profit, Operating, Gross MarginsGEHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • GEHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for GEHC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GEHC Yearly Shares OutstandingGEHC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M
GEHC Yearly Total Debt VS Total AssetsGEHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • GEHC has an Altman-Z score of 1.92. This is not the best score and indicates that GEHC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • GEHC has a Altman-Z score of 1.92. This is in the better half of the industry: GEHC outperforms 61.08% of its industry peers.
  • GEHC has a debt to FCF ratio of 7.38. This is a slightly negative value and a sign of low solvency as GEHC would need 7.38 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 7.38, GEHC is in the better half of the industry, outperforming 75.14% of the companies in the same industry.
  • GEHC has a Debt/Equity ratio of 0.83. This is a neutral value indicating GEHC is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.83, GEHC is not doing good in the industry: 72.43% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 7.38
Altman-Z 1.92
ROIC/WACC0.79
WACC9.79%
GEHC Yearly LT Debt VS Equity VS FCFGEHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • GEHC has a Current Ratio of 1.18. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
  • GEHC's Current ratio of 1.18 is on the low side compared to the rest of the industry. GEHC is outperformed by 81.08% of its industry peers.
  • A Quick Ratio of 0.95 indicates that GEHC may have some problems paying its short term obligations.
  • The Quick ratio of GEHC (0.95) is worse than 78.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.95
GEHC Yearly Current Assets VS Current LiabilitesGEHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 2.00% over the past year.
EPS 1Y (TTM)2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.13%

3.2 Future

  • GEHC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.96% yearly.
  • GEHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.10% yearly.
EPS Next Y9.67%
EPS Next 2Y10.7%
EPS Next 3Y10.13%
EPS Next 5Y8.96%
Revenue Next Year4.34%
Revenue Next 2Y4.43%
Revenue Next 3Y4.08%
Revenue Next 5Y3.1%

3.3 Evolution

GEHC Yearly Revenue VS EstimatesGEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
GEHC Yearly EPS VS EstimatesGEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • GEHC is valuated rather expensively with a Price/Earnings ratio of 18.39.
  • 84.32% of the companies in the same industry are more expensive than GEHC, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.99, GEHC is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 16.77 indicates a correct valuation of GEHC.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 85.95% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. GEHC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.39
Fwd PE 16.77
GEHC Price Earnings VS Forward Price EarningsGEHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • GEHC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GEHC is cheaper than 84.86% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 82.16% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 27.42
EV/EBITDA 13.34
GEHC Per share dataGEHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of GEHC may justify a higher PE ratio.
PEG (NY)1.9
PEG (5Y)N/A
EPS Next 2Y10.7%
EPS Next 3Y10.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.18%, GEHC is not a good candidate for dividend investing.
  • GEHC's Dividend Yield is rather good when compared to the industry average which is at 0.20. GEHC pays more dividend than 89.73% of the companies in the same industry.
  • With a Dividend Yield of 0.18, GEHC pays less dividend than the S&P500 average, which is at 1.85.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

  • GEHC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
GEHC Yearly Dividends per shareGEHC Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • 2.80% of the earnings are spent on dividend by GEHC. This is a low number and sustainable payout ratio.
DP2.8%
EPS Next 2Y10.7%
EPS Next 3Y10.13%
GEHC Yearly Income VS Free CF VS DividendGEHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
GEHC Dividend Payout.GEHC Dividend Payout, showing the Payout Ratio.GEHC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GE HEALTHCARE TECHNOLOGY

NASDAQ:GEHC (2/20/2026, 6:37:49 PM)

After market: 84.8155 +0.59 (+0.7%)

84.23

+1.22 (+1.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04
Earnings (Next)04-27
Inst Owners89.01%
Inst Owner Change1.56%
Ins Owners0.28%
Ins Owner Change-0.1%
Market Cap38.39B
Revenue(TTM)N/A
Net Income(TTM)2.22B
Analysts78.57
Price Target94.06 (11.67%)
Short Float %2.19%
Short Ratio2.93
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP2.8%
Div Incr Years1
Div Non Decr Years1
Ex-Date01-09
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.54%
Min EPS beat(2)-0.16%
Max EPS beat(2)13.24%
EPS beat(4)3
Avg EPS beat(4)8.5%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)5.72%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.92%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)-0.75%
Revenue beat(4)1
Avg Revenue beat(4)-0.9%
Min Revenue beat(4)-2.17%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.64%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.79%
PT rev (3m)5.97%
EPS NQ rev (1m)0.15%
EPS NQ rev (3m)0.19%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.01%
Valuation
Industry RankSector Rank
PE 18.39
Fwd PE 16.77
P/S 1.9
P/FCF 27.42
P/OCF 20.75
P/B 3.84
P/tB N/A
EV/EBITDA 13.34
EPS(TTM)4.58
EY5.44%
EPS(NY)5.02
Fwd EY5.96%
FCF(TTM)3.07
FCFY3.65%
OCF(TTM)4.06
OCFY4.82%
SpS44.42
BVpS21.93
TBVpS-10.12
PEG (NY)1.9
PEG (5Y)N/A
Graham Number47.53
Profitability
Industry RankSector Rank
ROA 6.14%
ROE 22.19%
ROCE 10.51%
ROIC 7.77%
ROICexc 9.18%
ROICexgc 27.2%
OM 13.52%
PM (TTM) 10.95%
GM 40.8%
FCFM 6.91%
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
ROICexc(3y)9.28%
ROICexc(5y)10.16%
ROICexgc(3y)32.48%
ROICexgc(5y)41.69%
ROCE(3y)11.31%
ROCE(5y)12.72%
ROICexgc growth 3Y-14.77%
ROICexgc growth 5YN/A
ROICexc growth 3Y-4.79%
ROICexc growth 5YN/A
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 7.38
Debt/EBITDA 2.51
Cap/Depr 78.67%
Cap/Sales 2.22%
Interest Coverage 5.09
Cash Conversion 55.91%
Profit Quality 63.15%
Current Ratio 1.18
Quick Ratio 0.95
Altman-Z 1.92
F-Score5
WACC9.79%
ROIC/WACC0.79
Cap/Depr(3y)60.52%
Cap/Depr(5y)52.47%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.73%
Profit Quality(3y)98.54%
Profit Quality(5y)74.63%
High Growth Momentum
Growth
EPS 1Y (TTM)2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.69%
EPS Next Y9.67%
EPS Next 2Y10.7%
EPS Next 3Y10.13%
EPS Next 5Y8.96%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.13%
Revenue Next Year4.34%
Revenue Next 2Y4.43%
Revenue Next 3Y4.08%
Revenue Next 5Y3.1%
EBIT growth 1Y8.91%
EBIT growth 3Y-2.07%
EBIT growth 5Y4.33%
EBIT Next Year18.38%
EBIT Next 3Y10.76%
EBIT Next 5Y9.55%
FCF growth 1Y-18.75%
FCF growth 3Y4.48%
FCF growth 5Y0.56%
OCF growth 1Y-11.61%
OCF growth 3Y6.68%
OCF growth 5Y1.2%

GE HEALTHCARE TECHNOLOGY / GEHC FAQ

What is the fundamental rating for GEHC stock?

ChartMill assigns a fundamental rating of 4 / 10 to GEHC.


What is the valuation status for GEHC stock?

ChartMill assigns a valuation rating of 6 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Fairly Valued.


How profitable is GE HEALTHCARE TECHNOLOGY (GEHC) stock?

GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.


What is the financial health of GE HEALTHCARE TECHNOLOGY (GEHC) stock?

The financial health rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10.


Can you provide the dividend sustainability for GEHC stock?

The dividend rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10 and the dividend payout ratio is 2.8%.